Boehringer buys cancer immunotherapy developer
Boehringer Ingelheim announced that it has acquired all shares of Austrian-based ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news